NASDAQ:LUCD
Days-to-cover ratio for LUCD surges to 6.0 due to rise in short interest
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or ...
An Analysis of Lucid Diagnostics Inc (LUCD)’s Potential Price Growth
Lucid Diagnostics Inc’s recently made public that its Director Matheis Dennis acquired Company’s shares for reported $0.1 million on Aug ...
The Attractiveness of Investing In Lucid Diagnostics Inc (LUCD) is Growing
Lucid Diagnostics Inc’s recent filing unveils that its Director Matheis Dennis acquired Company’s shares for reported $0.1 million on Aug ...
Investing in Lucid Diagnostics Inc (LUCD) Is Getting More Attractive
Lucid Diagnostics Inc’s recently made public that its Director Matheis Dennis acquired Company’s shares for reported $0.1 million on Aug ...
Analyzing Lucid Diagnostics Inc (LUCD) After Recent Trading Activity
Lucid Diagnostics Inc’s recent filing unveils that its Director Matheis Dennis acquired Company’s shares for reported $0.1 million on Aug ...
The Potential Rise in the Price of Lucid Diagnostics Inc (LUCD) following insiders activity
Lucid Diagnostics Inc’s recent filing unveils that its Director Matheis Dennis acquired Company’s shares for reported $0.1 million on Aug ...
Lucid Diagnostics Inc (LUCD) receives a Buy rating from Ascendiant Capital Markets
Lucid Diagnostics Inc’s recently made public that its Director Matheis Dennis acquired Company’s shares for reported $0.1 million on Aug ...
Potential Price Increase for Lucid Diagnostics Inc (LUCD) After Recent Insider Activity
Lucid Diagnostics Inc’s recent filing unveils that its Director Matheis Dennis acquired Company’s shares for reported $0.1 million on Aug ...
